Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia

Journal of Critical Care

Volumn 25, Issue 1, 2010, Pages 176.e7-176.e13

  Lee, Yao Ling ^a   Chen, Wei ^b   Chen, Ling Yun ^a   Chen, Chia Hung ^b   Lin, Yu Chao ^b   Liang, Shinn Jye ^b   Shih, Chuen Ming ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute respiratory distress syndrome; Bronchoalveolar lavage fluid; Community acquired pneumonia; Cytokines; Interleukin

Indexed keywords

C REACTIVE PROTEIN; ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROTEIN EXPRESSION; SURVIVAL; UNIVERSITY HOSPITAL;

EID: 77049110558     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2009.05.002     Document Type: Article

References (42)

1. Waite S., Jeudy J., and White C.S. Acute lung infections in normal and immunocompromised hosts. Radiol Clin North Am 44 (2006) 295-315 [ix]
2. Happel K.I., Bagby G.J., and Nelson S. Host defense and bacterial pneumonia. Semin Respir Crit Care Med 25 (2004) 43-52
3. Rosseau S., Hocke A., Mollenkopf H., et al. Comparative transcriptional profiling of the lung reveals shared and distinct features of Streptococcus pneumoniae and influenza A virus infection. Immunology 120 (2007) 380-391
4. Confalonieri M., Potena A., Carbone G., et al. Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation. Am J Respir Crit Care Med 160 (1999) 1585-1591
5. Ruiz M., Arosio C., Salman P., et al. Diagnosis of pneumonia and monitoring of infection eradication. Drugs 60 (2000) 1289-1302
6. Kothe H., Bauer T., Marre R., et al. Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 32 (2008) 139-146
7. Monton C., and Torres A. Lung inflammatory response in pneumonia. Monaldi Arch Chest Dis 53 (1998) 56-63
8. Paganin F., Lilienthal F., Bourdin A., et al. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur Respir J 24 (2004) 779-785
9. El Solh A., Pineda L., Bouquin P., et al. Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers. BMC Geriatr 6 (2006) 12
10. Yende S., Tuomanen E.I., Wunderink R., et al. Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia. Am J Respir Crit Care Med 172 (2005) 1440-1446
11. Wu C.L., Lee Y.L., Chang K.M., et al. Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia. Crit Care Med 31 (2003) 812-817
12. Wu C.L., Chan M.C., Chang G.C., et al. Etiology and cytokine expression in patients requiring mechanical ventilation due to severe community-acquired pneumonia. J Formos Med Assoc 105 (2006) 49-55
13. Droemann D., Hansen F., Aries S.P., et al. Neutrophil apoptosis, activation and anti-inflammatory cytokine response in granulocyte colony-stimulating factor-treated patients with community-acquired pneumonia. Respiration 73 (2006) 340-346
14. von Dossow V., Rotard K., Redlich U., et al. Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients. Crit Care 9 (2005) R662-669
15. Kajon A.E., Gigliotti A.P., and Harrod K.S. Acute inflammatory response and remodeling of airway epithelium after subspecies B1 human adenovirus infection of the mouse lower respiratory tract. J Med Virol 71 (2003) 233-244
16. Mizgerd J.P., Spieker M.R., and Doerschuk C.M. Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coli pneumonia in mice. J Immunol 166 (2001) 4042-4048
17. Babu P.B., Chidekel A., and Shaffer T.H. Association of interleukin-8 with inflammatory and innate immune components in bronchoalveolar lavage of children with chronic respiratory diseases. Clin Chim Acta 350 (2004) 195-200
18. Muehlstedt S.G., Richardson C.J., West M.A., et al. Cytokines and the pathogenesis of nosocomial pneumonia. Surgery 130 (2001) 602-609 [discussion 609-611]
19. Andrews P., Azoulay E., Antonelli M., et al. Year in review in intensive care medicine. 2005. I. Acute respiratory failure and acute lung injury, ventilation, hemodynamics, education, renal failure. Intensive Care Med 32 (2006) 207-216
20. Neuhaus T., and Ewig S. Defining severe community-acquired pneumonia. Med Clin North Am 85 (2001) 1413-1425
21. Ewig S., Schafer H., and Torres A. Severity assessment in community-acquired pneumonia. Eur Respir J 16 (2000) 1193-1201
22. Fine M.J., Smith M.A., Carson C.A., et al. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 275 (1996) 134-141
23. Requilme R., Torres A., El-Ebiary M., et al. Community-acquired pneumonia in the elderly. A multivariate analysis of risk and prognostic factor. Am J Respir Crit Care Med 154 (1996) 1450-1455
24. Kang C.I., Song J.H., Oh W.S., Ko K.S., Chung D.R., and Peck K.R. Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study Group. Clinical outcomes and risk factors of community-acquired pneumonia caused by gram-negative bacilli. Eur J Clin Microbiol Infect Dis 27 8 (2008) 657-661
25. Mehrad B., and Standiford T.J. Role of cytokines in pulmonary antimicrobial host defense. Immunol Res 20 (1999) 15-27
26. Loanas M., Ferrer M., Cavalcanti M., et al. Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia. Crit Care Med 32 (2004) 938-945
27. Meduri G.U., Kohler G., Headley S., et al. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 108 (1995) 1303-1314
28. Monton C., Torres A., El-Ebiary M., et al. Cytokine expression in severe pneumonia: a bronchoalveolar study. Crit Care Med 27 (1999) 1745-1753
29. Nys M., Ledoux D., Canivet J.L., et al. Correlation between endotoxin level and bacterial count in bronchoalveolar lavage fluid of ventilated patients. Crit Care Med 28 (2000) 2825-2830
30. Stephens K.E., Ishizaka A., Larrick J.W., et al. Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. Am Rev Respir Dis 137 (1988) 1364-1370
31. Miller E.J., Cohen A.B., Nagao S., et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 146 (1992) 427-432
32. Li J.J., Sanders R.L., McAdam K.P., et al. Impact of C-reactive protein (CRP) on surfactant function. J Trauma 29 (1989) 1690-1697
33. Lobo S.M., Lobo F.R., Lopes-Ferreira F., et al. Initial and delayed onset of acute respiratory failure: factors associated with development and outcome. Anesth Analg 103 (2006) 1219-1223
34. Martin M.A., and Silverman H.J. Gram-negative sepsis and the adult respiratory distress syndrome. Clin Infect Dis 14 (1992) 1213-1228
35. Cepkova M., Brady S., Sapru A., et al. Biological markers of lung injury before and after the institution of positive pressure ventilation in patients with acute lung injury. Crit Care 10 (2006) R126
36. Ewig S., and Torres A. Severe community-acquired pneumonia: how to assess illness severity. Monaldi Arch Chest Dis 54 (1999) 250-254
37. Agarwal R., Aggarwal A.N., Gupta D., Behera D., and Jindal S.K. Etiology and outcomes of pulmonary and extrapulmonary acute lung injury/ARDS in a respiratory ICU in North India. Chest 130 3 (2006) 724-729
38. Khan N.A., Palepu A., Norena M., Ayas N., Wong H., Chittock D., et al. Differences in hospital mortality among critically ill patients of Asian, Native Indian and European descent. Chest (2008) [Electronic publication pub ahead of print]
39. Terminella L., and Sharma G. Diagnostic studies in patients with acute respiratory distress syndrome. Semin Thorac Cardiovasc Surg 18 (2006) 2-7
40. Barry S.M., and Janossy G. Optimal gating strategies for determining bronchoalveolar lavage CD4/CD8 lymphocyte ratios by flow cytometry. J Immunol Methods 285 (2004) 15-23
41. Effros R.M., Biller J., Foss B., et al. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med 168 (2003) 1500-1505
42. Metso T., Venge P., Haahtela T., et al. Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects. Thorax 57 (2002) 449-451